Manabu Tsukamoto

Manabu Tsukamoto

Auto-generated profile, based on publicly available information

Manabu Tsukamoto

Department of Orthopaedic Surgery, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, 807-8555, Japan

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Stem Cells International
Verified
Journal Article
Open access
PDF file
AHAkihisa Hatakeyama
Akihisa Hatakeyama
SUSoshi Uchida
Soshi Uchida
HUHajime Utsunomiya
Hajime Utsunomiya
MTManabu Tsukamoto
Manabu Tsukamoto
HNHirotaka Nakashima
Hirotaka Nakashima
ASAkinori Sakai
Akinori Sakai
Purpose. To determine the characteristics of MSCs from hip and compare them to MSCs from knee. Methods. Synovial tissues were obtained from both the knee and the hip joints in 8 patients who underwent both hip and knee arthroscopies on the same day. MSCs were isolated from the knee and hip synovial samples. The capacities of MSCs were compared between both groups. Results. The number of cells per unit weight at passage 0 of synovium from the knee was significantly higher than that from the hip (P<0.05). While it was possible to observe the growth of colonies in all the knee synovial fluid samples, it was impossible to culture cells from any of the hip samples. In adipogenesis experiments, the frequency of Oil Red-O-positive colonies and the gene expression of adipsin were significantly higher in knee than in hip. In osteogenesis experiments, the expression of COL1A1 and ALPP was significantly less in the knee synovium than in the hip synovium. Conclusions. MSCs obtained from hip joint have self-renewal and multilineage differentiation potentials. However, in matched donors, adipogenesis and osteogenesis potentials of MSCs from the knees are superior to those from the hips. Knee synovium may be a better source of MSC for potential use in hip diseases.

1 December 2017 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
MTManabu Tsukamoto
Manabu Tsukamoto
TMToshiharu Mori
Toshiharu Mori
HOHideo Ohnishi
Hideo Ohnishi
SUSoshi Uchida
Soshi Uchida
ASAkinori Sakai
Akinori Sakai

1 January 2017 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
MTManabu Tsukamoto
Manabu Tsukamoto
HOHideo Ohnishi
Hideo Ohnishi
TMToshiharu Mori
Toshiharu Mori
MKMakoto Kawasaki
Makoto Kawasaki
SUSoshi Uchida
Soshi Uchida
ASAkinori Sakai
Akinori Sakai

12 July 2020 in Journal of Bone and Mineral Metabolism
Verified
Journal Article
Open access
PDF file
HKHideomi Kondo
Hideomi Kondo
NONobukazu Okimoto
Nobukazu Okimoto
TYToru Yoshioka
Toru Yoshioka
SAShojiro Akahoshi
Shojiro Akahoshi
YFYoshifumi Fuse
Yoshifumi Fuse
ASAkinori Sakai
Akinori Sakai
Introduction Rapid descent in bone mineral density (BMD) and ascent in bone turnover marker (BTM) occur within the short period following denosumab (Dmab) discontinuation. In addition, the incidence of vertebral fracture also rises within the short period. The purpose of this study is to investigate the effects of sequential therapy using zoledronic acid (ZOL) on any adverse events after Dmab discontinuation. Materials and methods This study was a multicenter retrospective observational study, and the subjects were osteoporosis patients who visited our institutions between 2013 and 2018. We performed sequential therapy using ZOL for 30 patients who had difficulty continuing Dmab, due to physical or social reasons, and investigated the fracture incidence and BMD/BTM changes at 4 time points (at the start of Dmab, the start of ZOL, 6 months after ZOL and 12 months after ZOL). Results No new vertebral/nonvertebral fractures were observed at each time point after switching from Dmab to ZOL in any of the 30 patients. The BMD/BTM changes were evaluated in 18 of the 30 cases, since all data of lumbar/femoral neck BMDs and TRACP-5b at 4 time points was only available in 18 cases. BMDs significantly increased at each time point compared with that at the start of Dmab. Serum TRACP-5b significantly decreased at each time point compared with that at the start of Dmab. Conclusion It was suggested that sequential therapy using ZOL could suppress the decrease of BMD, and increase of BTM, if the period of Dmab administration was less than 3 years.

24 June 2019 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
PDF file
HNHirotaka Nakashima
Hirotaka Nakashima
MTManabu Tsukamoto
Manabu Tsukamoto
YOYasuo Ohnishi
Yasuo Ohnishi
HUHajime Utsunomiya
Hajime Utsunomiya
SKShiho Kanezaki
Shiho Kanezaki
SUSoshi Uchida
Soshi Uchida
Background: The acetabular labrum plays important roles in proprioception, nociception, synovial fluid seal effect, and static and dynamic joint stability and as a shock absorber. Clinical and radiographic risk factors for unsalvageable labral tear in femoroacetabular impingement (FAI) are not well established. Purpose: To identify predictors of unsalvageable labral tear during initial hip arthroscopic management of FAI. Study Design: Case-control study; Level of evidence, 3. Methods: Patients were included who underwent primary hip arthroscopic treatment for FAI between March 2009 and March 2014. Patients were excluded who had <2-year follow-up, underwent bilateral surgery, or had a history of surgery, osteoarthritis (Tönnis grade 2 or 3), and other diagnoses, including lateral center-edge angle <25° diagnosed as developmental hip dysplasia. Patients were divided into 2 groups according to their labral condition: reconstruction and refixation. Unsalvageable labral tear was defined as any irreparable labral tear, including severe degenerative tear, frayed labrum, labral ossification, flattened labrum, and failed prior repair during surgery. Univariate and multivariate analyses identified risk factors for segmental labral reconstruction. Patient-reported outcome scores and postoperative revision rates were also assessed. Results: Twenty-five hips (18 male, 7 female) and 126 hips (65 male, 61 female) were included in the reconstruction and refixation groups, respectively. The mean ± SD ages were 52.6 ± 15.0 and 36.5 ± 16.1 years in the reconstruction and refixation groups, respectively. In the reconstruction group, the mean modified Harris Hip Score significantly improved from 67.3 ± 14.9 preoperatively to 95.0 ± 8.1 at final follow-up ( P < .001), and the mean Nonarthritic Hip Score improved from 63.0 ± 18.3 preoperatively to 89.5 ± 10.1 at final follow-up ( P < .001). In the refixation group, the mean modified Harris Hip Score significantly improved from 69.2 ± 18.6 preoperatively to 93.0 ± 11.2 at final follow-up ( P < .001), and the mean Nonarthritic Hip Score improved from 60.7 ± 18.8 preoperatively to 88.6 ± 15.0 at final follow-up ( P < .001). No significant difference was noted in patient-reported outcome scores and revision hip arthroscopy rates. The rate of conversion of total hip arthroplasty was higher in the reconstruction group than in the refixation group. Risk factors for unsalvageable labral tear were age ≥45 years (odds ratio [OR], 8.83; P < .007), body mass index ≥23.1 kg/m 2 (OR, 13.05; P < .001), and vertical center anterior angle ≥36° (OR, 19.03; P < .001). Furthermore, in this study, unsalvageable labral tears were present in cases with at least 2 of the 3 risk factors. Conclusion: Age ≥45 years, body mass index ≥23.1 kg/m 2 , and vertical center anterior angle ≥36° are risk factors for unsalvageable labral tear at initial hip arthroscopic surgery for patients with FAI.

26 September 2022 in Journal of Bone and Mineral Metabolism
Verified
Journal Article
Closed access
PDF file
YMYosuke Mano
Yosuke Mano
MTManabu Tsukamoto
Manabu Tsukamoto
KWKe-Yong Wang
Ke-Yong Wang
TNTakayuki Nabeshima
Takayuki Nabeshima
KKKenji Kosugi
Kenji Kosugi
ASAkinori Sakai
Akinori Sakai